Abstract
Opioid agonists represent a group of natural, semisynthetic, or synthetic drugs with the ability to relieve pain but with the potential risk to provoke physical dependence. Structurally, opioids are phenanthrene derivatives (morphine), phenypiperidine derivatives (fentanyl), diphenylheptane derivatives (methadone),1 and pep tide-related compounds (en- dorphin, enkephalin, and dynorphin).2 Opioids exert their major pharmacologic effect on the central nervous system, however, they also interact with the immune system by altering macrophage, natural killer (NK) cell, and lymphocyte functions, thus impairing immunity against infectious diseases and cancer.3-7 Opioid agonist activities depend on binding to high-affinity receptors named μ, k, and δ which been found on cells of the immune system.2.8-10
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
McEvoy, G. K., Opiate agonists, in American Hospital Formulary Service Drug Information, G. K. McEvoy, Ed., American Society of Health-System Pharmacists, Bethesda, 1995.
Carr, D. J. J., The role of endogenous opioids and their receptors in the immune system, Proc. Soc. Exp. Biol.Med., 198, 710, 1991.
Guan, L., Towsend, R., Eisenstein, T. K., Adler, M. W., and Rogers, T. J., The cellular basis for opioid-induced immunosuppression, Adv. Exp. Med. BioL, 373, 57, 1995.
Roy, S., and Loh, H. H., Effects of opioids on the immune system, Neurochem. Res. 21, 1375, 1996.
Tubaro, E., Borelli, G., Croce, C, Cavallo, G., and Santiangeli, C, Effect of morphine on resistance to infection, J. Infect. Dis., 148, 656, 1983.
Watson, R. R., Prabhala, R. H., Darban, H. R, Yahya, M. D., and Smith, T. L., Changes in lymphocyte and macrophage subsets due to morphine and ethanol treatment during a retrovirus infection causing murine AIDS, Life Sci., 43, v, 1988.
Yeager, M. P., and Colacchio, T. A., Effect of morphine on growth of metastatic colon cancer in vivo, Arch. Surg., 126, 454, 1991.
Lord, J. A., Waterfield, A. A., Hughes, J., and Kosterlitz, H. W., Endogenous opioid peptides: multiple agonists and receptors, Nature, 267, 495, 1977.
Carr, D. J. J., Rogers, T. J., and Weber, R. J., The relevance of opioid receptors on immunocompetence and immune homeostasis, Proc. Soc. Exp. Biol Med., 213, 248, 1996.
Rouveix, B., Opiates and immune function. Consequences on infectious diseases with special reference to AIDS, Therapie, 47, 503, 1992.
Gorczynski, R. M., Control of the immune response: role of macrophages in regulation of antibody and cell-mediated immune responses, Scan. J. Immunol., 5, 1031, 1976.
Mackaness, G. B., Cellular resistance to infection, J. Exp. Med., 116, 381, 1962.
Steigbigel, R. T., Lambert, L. H., and Remington, J. S., Phagocytic and bactericidal properties of normal human monocytes, J. Clin. Invest., 53, 131, 1974.
Adams, D. O., Johnson, W. J., and Marino, P. A., Mechanisms of target destruction in macrophage-medi-ated tumor cytotoxicity, Fed. Proc, 41, 2212, 1982.
Adams, D. O., Macrophage activation and secretion. Fed. Proc. 41, 2193, 1982.
Nathan, C. F., Murray, H. W., and Cohn, Z. A., The macrophage as an effector cell, N. Engl. J. Med., 303, 622, 1980.
Douglas, S. D., Mononuclear phagocytes and tissue regulatory mechanisms, Dev. Comp. Immunol., 4, 7, 1980.
Meltzer, M. S., Occhionero, M., and Ruco, L. P., Macrophage activation for tumor cytotoxicity: regulatory mechanisms for induction and control of cytotoxic activity, Fed. Proc, 41, 2198, 1982.
Ruco, L. P., and Meltzer, M. S., Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions, J. Immunol, 121, 2035, 1978.
Nathan, C, and Hibb, J. B. Jr., Role of nitric oxide synthesis in macrophage antimicrobial activity, Curr. Opin. Immunol, 3, 65, 1991.
Hibbs, J. B. Jr., Taintor, R. R., Vavrin, Z., and Rachlin, E. M., Nitric oxide: a cytotoxic activated macrophage effector molecule, Biochem. Biophys. Res. Commun., 157, 87, 1988.
Flescher, E., Gonen, P., and Keisari, Y., Oxidative burst-dependent tumoricidal and tumorostatic activities of paraffin oil-elicited mouse macrophages, J. Natl. Cancer Inst., 72, 1341, 1984.
Nathan, C. F., Macrophage microbicidal mechanisms, Trans. Roy. Soc. Trop. Med. Hyg., 77, 620, 1983.
Gangadharam, P. R. J., and Edwards III, C. K., Release of Superoxide anion from resident and activated mouse peritoneal macrophages infected with Mycobacterium intracellulare, Am. Rev. Respir. Dis., 130, 834, 1984.
Gangadharam, P. R. J, and Pratt, P. F., Susceptibility of Mycobacterium intracellulare to hydrogen peroxide, Am. Rev. Respir. Dis., 130, 309, 1984.
Fortier, A. H., Polsinelli, T., Green, S. J., and Nacy, C. A., Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules, Infect. Immun., 60, 817, 1992.
Becjerman, K. P., Rogers, H. W., Corbett, J. A., Schreiber, R. D., McDaniel, M. L., and Unanue, E. R., Release of nitric oxide during T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes, J. Immunol, 150, 888, 1993.
Denis, M., Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates, Cell Immunol., 132, 150, 1991.
Denis, M., Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates, J. Leukoc. Biol., 49, 380, 1991.
Alspaugh, J. A., and Granger, D. L., Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis, Infect. Immun., 59, 2291, 1991.
Mauel, J., Ransijn, A., and Buchmuller-Rouiller, Y, Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivatives, J. Leukoc. Biol 49, 73, 1991.
Lepoivre, M., Fieschi, F., Coves, J., Thelander, L., and Fontecave, M., Inactivation of ribonucleotide reduc-tase by nitric oxide, Biochem. Biophys. Res. Commun. 179, 442, 1991.
Moncada, S., Palmer, R. M. J., and Higgs, E. A., Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol. Rev., 43, 109, 1991.
Ding, A., Nathan, C. F., and Stuehr, D. J., Release of reactive nitrogen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production, J. Immunol. 141, 2407, 1988.
Drapier, J. C, Wietzerbin, J., and Hibbs, J. B. Jr., Interferon-γ and tumor necrosis factor induce the L-ar-ginine-dependent cytotoxic effector mechanism in murine macrophages, Eur. J. Immunol., 18, 1587, 1988.
Hibbs, J. B. Jr., Granger, D. L., Krahenbuhl, J. L., and Adams, L. B., Synthesis of nitric oxide from L-arginine: a cytokine inducible pathway with antimicrobial activity, in Mononuclear phagocytes, R. van Furth, Ed., Kluwer Academic Publishers, Boston, 1992.
Lowestein, C. J., Alley, E., Raval, P., Snyder, S. H., Russel, S. W., and Murphy, W., Nitric oxide synthase gene: two upstream regions mediate its induction by interferon-gamma and lipopolysaccharide, Proc. Natl. Acad. Sci. U. S. A., 90, 9730, 1993.
Germain, R. H., and Marguiles, D. M., The biochemistry and cell biology of antigen processing and presentation, Ann. Rev. Immunol., 11, 403, 1993.
Unanue, E. R., and Allen, P. M., The basis for the immunoregulatory role of macrophages and other accessory cells, Science, 236, 551, 1987.
Zinkernagel, R. M., and Doherty, P. C, Activity of sensitized thymus-derived lymphocytes in lymphocytic choriomeningitis reflects immunological surveillance against self components, Nature, 251, 547, 1974.
Bonta, I. L., and Ben-Efraim S., Involvement of inflammatory mediators in macrophage antitumor activity, J. Leukoc. Biol., 54, 613, 1993.
Mukaida, N., Inflammation and pro-inflammatory cytokines, Jpn. J. Clin. Med., 50, 1724, 1992.
Si-Xun, Y, and Xiao-Yu, L., Enhancement of interleukin-1 production in mouse peritoneal macrophages by methionine-enkephalin, Acta Pharmacol. Sin., 10, 266, 1989.
Marotti, T., Burek, B., Rabatic, S., Balog, T., and Hrsak, I., Modulation of lipopoiysaccharide-induced production of cytokines by methionine-enkephalin, Immunol. Lett., 40, 43, 1994.
Das, K. P., McMillian, M. K., Bing, G., and Hong, J. S., Modulatory effects of [Met5]-enkephalin on inter-leukin-1 beta secretion from microglia in mixed brain cell cultures, J. Neuroimmunol., 62, 9, 1995.
Apte, R. N., Durum, S. K., and Oppenheim, J. J., Opioids modulate interleukin-1 production and secretion by bone-marrow macrophages, Immunol. Lett., 24, 141, 1990.
Apte, R. R, Oppenheim, J. J., and Durum, S. K., β-Endorphin regulates interleukin 1 production and release by murine bone marrow macrophages, Int. Immunol., 1, 465, 1989.
Van den Bergh, P., Rozing, J., and Nagelkerken, L., β-Endorphin stimulates la expression on mouse B cells by inducing interleukin-4 secretion by CD4+ T cells, Cell. Immunol., 149, 180, 1993.
Bian, T. H., Wang, X. F., and Li, X. Y., Effect of morphine on interleukin-1 and tumor necrosis factor alpha production from mouse peritoneal macrophages in vitro, Acta Pharmacol Sin., 16, 449, 1995.
Belkowski, S. M., Alicea, C, Eisenstein, T. K., Adler, M. W., and Rogers, T. J., Inhibition of interleukin-1 and tumor necrosis factor-α synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H, J. Pharmacol Exp. Ther., 273, 1491, 1995.
Alicea, C, Belkowski, S., Eisenstein, T. K., Adler, M. W., and Rogers, T. J., Inhibition of primary murine macrophage cytokine production in vitro following treatment with the k-opioid agonist U50, 488H, J. Neuroimmunol., 64, 83, 1996.
Peterson, P. K., Gekker, G., Hu, S., Anderson, W. R., Kravitz, F., Portoghese, P. S., Balfour, H. H. Jr., and Chao, C. C, Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells, J. Neuroimmunol., 50, 167, 1994.
Chao, C. C, Gekker, G., Sheng, W. S., Hu, S., Tsang, M., and Peterson, P. K., Priming effect of morphine on the production of tumor necrosis factor-a by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression, J.Pharmacol Exp. Ther., 269, 198, 1994.
Chao, C. C, Gekker, G., Hu, S., Sheng, W. S., Portoghese, P. S., and Peterson, P. K., Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin, Bio-chem. Pharmacol., 50, 715, 1995.
Weber, R. J., and Pert, A., The periaqueductal gray matter mediates opiate-induced immunosuppression, Science, 245, 188, 1989.
Weber, R. J., and Pert, A., Immune system, in Encyclopedia of Neuroscience, Smith, B., and Adelman, G., Birkhauser Boston, Cambridge, MA, in press, 1997.
Bian, T. H., and Li, X. Y., Immunomodulating effects of morphine microinjected into periaqueductal gray, Acta Pharmacol Sin., 16, 121, 1995.
House, R. V., Thomas, P. T., and Bhargava, H. N., A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides, Peptides, 17, 75, 1996.
Tosk, J. M., Grim, J. R., Kinback, K. M., Sale, E. J., Bozzetti, L. P., and Will, D., Modulation of chemilu-minescence in a murine macrophage cell line by neuroendocrine hormones, Int. J. Immunopharmacol., 15, 615, 1993.
Sharp, B. M., Keane, W. F., Suh, H. J., Gekker, G., Tsukayama, D., and Peterson, P. K., Opioid peptides rapidly stimulate Superoxide production by human polymoprhonuclear leukocytes and macrophages, Endocrinology, 117, 793, 1985.
Peterson, P. K., Sharp, B. M., Gekker, G., Brummitt, C, and Keane, W.F., Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity, J. Immunol., 138, 3907, 1987.
Radulovic, J., Dimitrijevic, M., Laban, O., Stanojevic, S., Vasiljevic, T., Kovacevic-Jovanovic, V., and Markovic, B. M., Effect of met-enkephalin and opioid antagonists on rat macrophages, Peptides, 16, 1209, 1995.
Efanov, A. M., Koshkin, A. A., Sazanov, L. A., Borodulina, O. I., Varfolomeev, S. D., and Zaitsev, S. V., Inhibition of the respiratory burst in mouse macrophages by ultra-low doses of an opioid peptide is consistent with a possible adaptation mechanism. FEBS Lett. 355, 114, 1994.
Stuehr, D. J., and Nathan, C. F., Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells, J. Exp. Med., 169, 1543, 1989.
Pacifici, R., Minetti, M., Zuccaro, P., and Pietraforte, D., Morphine affects cytostatic activity of macrophages by the modulation of nitric oxide release, Int. J. Immunopharmacol. 17, 771, 1995.
Fecho, K., Maslonek, K. A., Coüssons-Read, M. E., Dykstra, L. A., and Lysle, D. T., Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo, J. Immunol. 152, 5845, 1994.
Magazine, H. I., Liu, Y, Bilflnger, T. V., Fricchione, G. L., and Stefano, G. B., Morphine-induced confor-mational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immuno-cytes and microglia are mediated by nitric oxide, J. Immunol., 156, 4845, 1996.
Schneider, G. M., and Lysle, D. T., Evidence for the involvement of CNS in the modulation of splenic nitric oxide production, J. Neuroimmunol., 69, 25, 1996.
Iuvone, T., Capasso, A., D’Acquisto, F, and Carnuccio, R., Opioids inhibit the induction of nitric oxide synthase in J774 macrophages, Biochem. Biophys. Res. Commun., 212, 975, 1995.
Adams, D. O., and Hamilton, T. A., The cell biology of macrophage activation, Ann. Rev. Immunol., 2, 283, 1984.
Appelberg, R., Castro, A. G., Pedrosa, J., Silva, R. A., Orme, I. M., and Minóprio P., Role of gamma inter-feron and tumor necrosis factor alpha during T-eell-independent and-dependent phases of Mycobacterium avium infection. Infect. Immun. 62, 3962, 1994.
Tubaro, E., Avico, U., Santiangeli, C, Zuccaro, P., Cavallo, G., Pacifici, R., Croce, C, and Borelli, G., Morphine and methadone impact on human phagocytic physiology, Int. J. Immunopharmacol., 7, 865, 1985.
Tubaro, E., Santiangeli, C, Belogi, L., Borelli, G., Cavallo, G., Croce, C, and Avico, U., Methadone vs morphine: comparison of their effect on phagocytic functions, Int. J. Immunopharmacol., 9, 79, 1987.
Rojavin, M., Szabo, I., Bussiere, J. L., Rogers, T. J., Adler, M. W., and Eisenstein, T. K., Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages, Life Sci., 53, 997, 1993.
Casellas, A. M., Guardiola, H., and Renaud, F. L., Inhibition by opioids of phagocytosis in peritoneal macrophages, Neuropeptides, 18, 35, 1991.
Szabo, I., Rojavin, M., Bussiere, J. L., Eisenstein, T. K., Adler, M. W., and Rogers, T. J., Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids, J. Pharmacol. Exp. Ther., 267, 703, 1993.
Fóris, G., Medgyesi, G. A., and Hauck, M., Bidirectional effect of met-enkephalin on macrophage effector functions, Mol. Cell. Biochem., 69, Ml, 1986.
Carrera, J., Catala, J. C, Monedero, P., Carrascosa, F., Arroyo, J. L., and Subira, M. L., Depression of the mononuclear phagocyte system caused by high doses of narcotics, Rev. Med. Univ. Navarra, 37, 119, 1992.
Peterson, P. K., Gekker, G., Hu, S. X., Sheng, W. S., Molitor, T. W., and Chao, C. C, Morphine stimulates phagocytosis of Mycobacterium tuberculosis by human microglial cells: involvement of a G protein-coupled opiate receptor, Adv. Neuroimmunol., 5, 299, 1995.
Ichinose, M., Asai, M., and Sawada, M., Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages, J. Neuroimmunol., 60, 37, 1995.
Lin, J., Ageing suppresses the enhancement of T cell mitogenesis by opioid peptides and enkephalins increase phagocytosis of murine macrophages, Acta Acad.Med. Sin., 14, 233, 1992.
Lopker, A., Abood, L. G., Hoss, W., and Lionetti, F. J., Stereoselective muscarinic acethylcholine and opiate receptors in human phagocytic leukocytes, Biochem. Pharmacol., 29, 1361, 1980.
Bryant, H. V., and Roudebush, R. E., Suppressive effects of morphine pellet implants on in vivo parameters of immune functions, J. Pharmacol. Exp. Ther., 255, 410, 1990.
Bryant, H. V., Bernton, E. W., Kenner, J. R., and Holaday, J. W., Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment, Endocrinology, 128, 3253, 1991.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gomez-Flores, R., Weber, R.J. (1998). Immunomodulation of Macrophage Functions by Opioids. In: Friedman, H., Madden, J.J., Klein, T.W. (eds) Drugs of Abuse, Immunomodulation, and Aids. Advances in Experimental Medicine and Biology, vol 437. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5347-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5347-2_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7439-8
Online ISBN: 978-1-4615-5347-2
eBook Packages: Springer Book Archive